Articles About NYSE:NVS
April 08, 2014
Why haven’t major American pharmaceutical companies joined the “green rush?”
March 19, 2014
Novartis stock has been on a strong run but is now pulling back.
March 18, 2014
Israeli stem-cell therapy developer Gamida-Cell Ltd. has received a buyout offer from an unnamed buyer; an Israeli news source claims that buyer is Novartis.
March 07, 2014
Novartis' blood cancer drug Jakavi met its primary endpoint in a late-stage clinical trial evaluating the drug in patients with a rare bone marrow disease.
March 04, 2014
Novartis stock has been on a strong run, but is now pulling back.
March 03, 2014
Novartis chair Joerg Reinhardt has denied speculation into a possible merger between Novartis and its Swiss competitor Roche.
February 26, 2014
Novartis joins competitors in a clinical trial data transparency effort that would allow medical researchers access to patient-level data of new medicines.
February 23, 2014
The Tokyo offices of Novartis' Japanese unit was raided by prosecutors on Wednesday following allegations that the company manipulated data.
February 18, 2014
Novartis stock has been on a strong run and is now trading near all-time high prices.
February 17, 2014
Novartis has acquired CoStim Pharmaceuticals for an undisclosed amount in a move that will likely help the company compete with rival immunotherapy programs.